Publication | Closed Access

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy

Surgical OncologyNeoadjuvant ChemotherapyEpithelial Ovarian CancerMedicineCancer ManagementGynecologySurgeryCancer TreatmentInterval DebulkingOncologyRadiation OncologyGynecology OncologyOvarian Cancer